Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,464,183 papers from all fields of science
Search
Sign In
Create Free Account
PET Response Criteria in Solid Tumors
Known as:
PERCIST
From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. (Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Nuclear Oncology
H. Strauss
,
G. Mariani
,
D. Volterrani
,
S. Larson
Cambridge International Law Journal
2017
Corpus ID: 42135209
Cancer is a complex series of stepwise genetic alterations resulting in common biologic changes in the transformed cells…
Expand
2015
2015
The relationship between primary lesion glucose metabolism of NSLC and chemotherapy: A preliminary study according to PERCIST criteria
Yaming Li
,
Na Li
,
Bulin Du
,
Meijie Chen
2015
Corpus ID: 132977766
2014
2014
Comparing response rates using RECIST, EORTC and PERCIST criteria for response evaluation in patients with non-small-cell lung cancer
Xue-ying Ling
,
Shang Jingjie
,
Yongjin Tang
,
Zeyu Xiao
,
Hao Xu
2014
Corpus ID: 69008772
2013
2013
The PERCIST criteria: an insightful appraisal.
A. Maffione
,
A. Ferretti
,
S. Vinjamuri
,
D. Rubello
Nuclear medicine communications
2013
Corpus ID: 8181318
Department of Imaging, Nuclear Medicine, Radiology, Interventional Radiology, Neuroradiology and Medical Physics, PET Unit…
Expand
2013
2013
Assessing PERCIST 1.0 non-measurable (low FDG uptake) lesions in patients with breast cancer does not diminish the predictive value of FDG PET
Joo Hyun Oo
,
J. Leal
,
V. Stearns
,
R. Wahl
2013
Corpus ID: 68573578
Review
2012
Review
2012
A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma.
J. Herman
,
D. Chang
,
+17 authors
A. Koong
2012
Corpus ID: 220745782
4045 Background: Phase I/II studies with single-fraction (25 Gy) stereotactic body radiotherapy (SBRT) for pancreatic ductal…
Expand
2012
2012
Response evaluation with total lesion glycolysis in patients with malignant lymphoma: Comparison to SULpeak in PERCIST on 18F-FDG PET/CT study
T. Watabe
,
M. Tatsumi
,
+7 authors
J. Hatazawa
2012
Corpus ID: 74579665
2012
2012
Evaluation of circulating tumor cells (CTCs) enumeration and 18F-Choline positron emission tomography/computed tomography (FCH PET/CT) as early efficacy response biomarkers in metastatic castration…
S. Le Moulec
,
C. Massard
,
+7 authors
K. Fizazi
Journal of Clinical Oncology
2012
Corpus ID: 9479933
63 Background: Circulating tumor cells (CTCs) and FCH PET/CT are both promising tools for treatment monitoring in CRPC pts. In…
Expand
Review
2012
Review
2012
DiagnostiC stRategies aimeD to monitoR CanCeR Patients tReateD with new moleCulaR
J. Camilo
,
C. Vasquez
,
J. R. Enciso
2012
Corpus ID: 79192941
2SUMMARY it is very important to have an objective evaluation of the response to cancer therapy. the standardization and use of a…
Expand
Review
2010
Review
2010
Targeting Angiogenesis in Non-Small Cell Lung Cancer (NSCLC)
A. Kotsakis
,
T. Owonikoko
2010
Corpus ID: 14648125
The management of NSCLC has undergone a paradigm shift in the last 5 years with the survival advantage demonstrated by the…
Expand